Dna Brands Stock Fundamentals
| DNAX Stock | USD 0.0002 0.0001 100.00% |
DNA Brands fundamentals help investors to digest information that contributes to DNA Brands' financial success or failures. It also enables traders to predict the movement of DNA Pink Sheet. The fundamental analysis module provides a way to measure DNA Brands' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DNA Brands pink sheet.
DNA |
DNA Brands Company Price To Earning Analysis
DNA Brands' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current DNA Brands Price To Earning | 0.20 X |
Most of DNA Brands' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DNA Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, DNA Brands has a Price To Earning of 0.2 times. This is 99.05% lower than that of the Beverages sector and significantly higher than that of the Consumer Staples industry. The price to earning for all United States stocks is 99.3% higher than that of the company.
DNA Brands Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DNA Brands's current stock value. Our valuation model uses many indicators to compare DNA Brands value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DNA Brands competition to find correlations between indicators driving DNA Brands's intrinsic value. More Info.DNA Brands is rated below average in operating margin category among its peers. It also is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value DNA Brands by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DNA Brands' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DNA Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DNA Brands' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of DNA Brands could also be used in its relative valuation, which is a method of valuing DNA Brands by comparing valuation metrics of similar companies.DNA Brands is currently under evaluation in price to earning category among its peers.
DNA Fundamentals
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| Gross Profit | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Net Income | (1.25 M) | |||
| Cash And Equivalents | 499 | |||
| Total Debt | 2 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.92) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 1.14 | |||
| Market Capitalization | 33.98 K | |||
| Total Asset | 327 K | |||
| Retained Earnings | (30.44 M) | |||
| Working Capital | (3.12 M) | |||
| Current Asset | 319 K | |||
| Current Liabilities | 3.43 M |
About DNA Brands Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DNA Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DNA Brands using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DNA Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.